Showing 101-120 of 640 for: Cochrane Systematic Reviews > Cardiovascular 
- Calcium channel blockers for preventing acute tubular necrosis in kidney transplant recipients
Cochrane Systematic Reviews, 17-Oct-2007
The incidence of delayed graft function in cadaveric grafts has increased over the last few years due in part to the large demand for cadaveric kidneys necessitating the use of kidneys from marginal donors. Calcium channel blockers have the potential to r
- Calcium channel blockers versus other classes of drugs for hypertension
Cochrane Systematic Reviews, 9-Jan-2022
This is the first update of a review published in 2010. While calcium channel blockers (CCBs) are often recommended as a first-line drug to treat hypertension, the effect of CCBs on the prevention of cardiovascular events, as compared with other antihyper
- Calcium supplementation for the management of primary hypertension in adults
Cochrane Systematic Reviews, 19-Apr-2006
Metabolic studies suggest calcium may have a role in the regulation of blood pressure. Some epidemiological studies reported people with a higher intake of calcium tend to have lower blood pressure. Previous systematic reviews and meta-analyses reached co
- Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 21-Aug-2017
Carbonic anhydrase inhibitors such as acetazolamide cause a mild metabolic acidosis and may stimulate breathing. Some patients with severe chronic obstructive pulmonary disease (COPD) develop chronic hypercapnic ventilatory failure. In theory, they may be
- Cardioselective beta‐blockers for chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 19-Oct-2005
Beta-blocker therapy has a proven mortality benefit in patients with hypertension, heart failure and coronary artery disease, as well as during the perioperative period. These drugs have traditionally been considered contraindicated in patients with chron
- Cardioselective beta‐blockers for reversible airway disease
Cochrane Systematic Reviews, 21-Oct-2002
Beta-blocker therapy has mortality benefit in patients with hypertension, heart failure and coronary artery disease, as well as during the perioperative period. These drugs have traditionally been considered contraindicated in patients with reversible air
- Carotid artery stenting versus endarterectomy for treatment of carotid artery stenosis
Cochrane Systematic Reviews, 25-Feb-2020
Carotid artery stenting is an alternative to carotid endarterectomy for the treatment of atherosclerotic carotid artery stenosis. This review updates a previous version first published in 1997 and subsequently updated in 2004, 2007, and 2012.
- Carotid endarterectomy for asymptomatic carotid stenosis
Cochrane Systematic Reviews, 19-Oct-2005
Carotid endarterectomy (CEA) is of proven benefit in recently-symptomatic patients with severe carotid stenosis. Its role in asymptomatic stenosis is still debated. The Asymptomatic Carotid Surgery Trial (ACST) more than doubled the number of patients ran
- Carotid endarterectomy for carotid stenosis in patients selected for coronary artery bypass graft surgery
Cochrane Systematic Reviews, 7-Oct-2009
Carotid stenosis and coronary artery disease can occur simultaneously. In patients with coronary artery disease who are scheduled for coronary artery bypass graft (CABG) surgery, but who also have carotid artery stenosis, there is controversy about the ro
- Carotid endarterectomy for symptomatic carotid stenosis
Cochrane Systematic Reviews, 12-Sep-2020
Stroke is the third leading cause of death and the most common cause of long-term disability. Severe narrowing (stenosis) of the carotid artery is an important cause of stroke. Surgical treatment (carotid endarterectomy) may reduce the risk of stroke, but
- Catheter ablation for paroxysmal and persistent atrial fibrillation
Cochrane Systematic Reviews, 13-Mar-2012
Atrial fibrillation (AF) is the most common cardiac arrhythmia seen in cardiovascular departments. Treatments include medical interventions and catheter ablation. Due to uncertainties in medical therapies for AF, and the need to continue sinus rhythm, abl
- Central action beta‐blockers versus placebo for neuroleptic‐induced acute akathisia
Cochrane Systematic Reviews, 18-Oct-2004
Neuroleptic-induced akathisia is a common, distressing early-onset adverse effect of neuroleptic drugs. It has been associated with poor treatment compliance and an increased risk of relapse.
- Central venous access sites for the prevention of venous thrombosis, stenosis and infection
Cochrane Systematic Reviews, 14-Mar-2012
Central venous access (CVA) is widely used. However, its thrombotic, stenotic and infectious complications can be life-threatening and involve high-cost therapy. Research revealed that the risk of catheter-related complications varied according to the sit
- Cerebrolysin for acute ischaemic stroke
Cochrane Systematic Reviews, 14-Jul-2020
Cerebrolysin is a mixture of low-molecular-weight peptides and amino acids derived from porcine brain that has potential neuroprotective properties. It is widely used in the treatment of acute ischaemic stroke in Russia, Eastern Europe, China, and other A
- Cerebrospinal fluid drainage for thoracic and thoracoabdominal aortic aneurysm surgery
Cochrane Systematic Reviews, 17-Oct-2012
During aortic aneurysm surgery, cross-clamping can lead to inadequate blood supply to the spinal cord resulting in neurological deficit. Cerebrospinal fluid drainage (CSFD) may increase the perfusion pressure to the spinal cord and hence reduce the risk o
- Chelation therapy for atherosclerotic cardiovascular disease
Cochrane Systematic Reviews, 5-May-2020
Chelation therapy is promoted and practiced around the world as a form of alternative medicine in the treatment of atherosclerotic cardiovascular disease. It has been suggested as a safe, relatively inexpensive, non-surgical method of restoring blood flow
- Chinese herbal medicine suxiao jiuxin wan for angina pectoris
Cochrane Systematic Reviews, 23-Jan-2008
Suxiao jiuxin wan is widely used in China for angina pectoris.
- Chinese herbal medicines for hypercholesterolemia
Cochrane Systematic Reviews, 5-Jul-2011
Hypercholesterolemia is an important key contributory factor for ischemic heart disease and is associated with age, high blood pressure, a family history of hypercholesterolemia, and diabetes. Chinese herbal medicines have been used for a long time as lip
- Chinese herbal medicines for people with impaired glucose tolerance or impaired fasting blood glucose
Cochrane Systematic Reviews, 6-Oct-2009
Around 308 million people worldwide are estimated to have impaired glucose tolerance (IGT); 25% to 75% of these will develop diabetes within a decade of initial diagnosis. At diagnosis, half will have tissue-related damage and all have an increased risk f
- Chuanxiong preparations for preventing stroke
Cochrane Systematic Reviews, 3-Jun-2016
Stroke is a major healthcare problem and is one of the leading causes of death and serious long-term disability. Prevention of stroke is considered an important strategy. Chuanxiong is traditionally used in China in the treatment and prevention of stroke.
